Table 4.
Arterial blood lactate, alanine, and glycerol and plasma NEFA concentrations, as well as net hepatic balance data, under basal conditions and during the clamp study
| Parameter and Group | Basal (−20 to 0 min) |
Period 1 |
Period 2 |
||||
|---|---|---|---|---|---|---|---|
| 30 min | 60 min | 90 min | 120 min | 150 min | 180 min | ||
| Lactate, µmol/L | |||||||
| Chow | 295 ± 9 | 525 ± 92 | 704 ± 117 | 691 ± 57 | 743 ± 51 | 784 ± 58 | 877 ± 61 |
| HFFD | 241 ± 14 | 281 ± 19* | 331 ± 36* | 415 ± 50* | 469 ± 50* | 483 ± 66* | 485 ± 78* |
| HFFD + FUM | 262 ± 26 | 466 ± 151 | 628 ± 186 | 595 ± 161 | 634 ± 168 | 614 ± 119 | 611 ± 130 |
| Net hepatic lactate balance,a µmol·kg−1·min−1 | |||||||
| Chow | −6.0 ± 1.0 | 1.9 ± 4.9 | 6.3 ± 3.7 | 5.3 ± 2.6 | 4.2 ± 2.1 | 4.2 ± 2.3 | 1.6 ± 2.0 |
| HFFD | 2.7 ± 0.3* | 2.4 ± 0.5 | 1.2 ± 0.6* | 1.3 ± 0.5* | 1.1 ± 0.6* | 1.3 ± 0.6* | 2.0 ± 0.4* |
| HFFD + FUM | 4.3 ± 0.3* | −0.6 ± 2.9 | −1.3 ± 2.7 | −0.5 ± 1.9 | −0.7 ± 1.8 | −0.7 ± 1.7 | 0.2 ± 1.5† |
| Alanine, µmol/L | |||||||
| Chow | 276 ± 15 | 315 ± 22 | 336 ± 29 | 337 ± 22 | 327 ± 19 | 330 ± 24 | 328 ± 22 |
| HFFD | 226 ± 17 | 234 ± 15* | 214 ± 15* | 209 ± 19* | 199 ± 17* | 193 ± 21* | 195 ± 19* |
| HFFD + FUM | 196 ± 18* | 221 ± 17* | 227 ± 23* | 213 ± 22* | 205 ± 18* | 200 ± 17* | 186 ± 17* |
| Net hepatic alanine uptake, µmol·kg−1·min−1 | |||||||
| Chow | 2.3 ± 0.2 | 1.7 ± 0.4 | 1.8 ± 0.1 | 1.7 ± 0.1 | 2.6 ± 0.2 | 2.2 ± 0.2 | 3.0 ± 0.3 |
| HFFD | 1.1 ± 0.1* | 1.3 ± 0.1 | 1.1 ± 0.1* | 1.3 ± 0.1 | 1.3 ± 0.1* | 1.5 ± 0.1* | 1.4 ± 0.1* |
| HFFD + FUM | 1.2 ± 0.1* | 1.1 ± 0.1* | 1.4 ± 0.2 | 1.3 ± 0.2 | 1.5 ± 0.2* | 1.7 ± 0.2 | 1.7 ± 0.1* |
| Glycerol, µmol/L | |||||||
| Chow | 81 ± 15 | 27 ± 2 | 35 ± 4 | 31 ± 4 | 35 ± 5 | 34 ± 9 | 32 ± 6 |
| HFFD | 87 ± 8 | 47 ± 4 | 43 ± 6 | 51 ± 6 | 40 ± 5 | 52 ± 9 | 44 ± 8 |
| HFFD + FUM | 137 ± 13*† | 67 ± 5*† | 63 ± 7*† | 75 ± 8*† | 73 ± 4*† | 64 ± 6* | 70 ± 6*† |
| Net hepatic glycerol uptake, µmol·kg−1·min−1 | |||||||
| Chow | 1.9 ± 0.4 | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.7 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.7 ± 0.1 |
| HFFD | 1.3 ± 0.1 | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.8 ± 0.2 | 0.6 ± 0.1 |
| HFFD + FUM | 2.6 ± 0.3 | 1.1 ± 0.1 | 1.1 ± 0.2† | 1.5 ± 0.3*† | 1.3 ± 0.1† | 1.2 ± 0.1† | 1.6 ± 0.1*† |
| Arterial NEFA, µmol/L | |||||||
| Chow | 828 ± 101 | 219 ± 85 | 144 ± 24 | 97 ± 13 | 91 ± 18 | 66 ± 9 | 52 ± 5 |
| HFFD | 810 ± 48 | 281 ± 43 | 138 ± 44 | 122 ± 34 | 87 ± 31 | 109 ± 35 | 94 ± 39 |
| HFFD + FUM | 866 ± 107 | 222 ± 54 | 118 ± 39 | 129 ± 48 | 81 ± 20 | 78 ± 27 | 96 ± 20 |
| Net hepatic NEFA uptake, µmol·kg−1·min−1 | |||||||
| Chow | 2.1 ± 1.0 | 0.7 ± 0.5 | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.2 ± 0.1 | 0.2 ± 0.2 | 0.2 ± 0.0 |
| HFFD | 2.0 ± 0.3 | 0.8 ± 0.2 | 0.1 ± 0.2 | 0.3 ± 0.1 | 0.1 ± 0.2 | 0.2 ± 0.3 | 0.2 ± 0.0 |
| HFFD + FUM | 1.9 ± 0.4 | 0.4 ± 0.2 | 0.3 ± 0.2 | 0.5 ± 0.4 | 0.2 ± 0.1 | 0.2 ± 0.2 | 0.2 ± 0.1 |
Data are means ± SE. Arterial lactate, alanine, and glycerol are from whole blood samples; nonesterified fatty acids (NEFAs) are from plasma samples; n = 4, 8, and 6 for the Chow [data previously published (8)], high-fat and -fructose diet (HFFD), and HFFD + FUM groups, respectively. Where no symbols are shown, there are no differences between groups.
Negative values for balance data indicate net hepatic uptake.
P < 0.05 vs. Chow by post hoc analysis.
P < 0.05 vs. HFFD by post hoc analysis.